Dybbs Michael
SEC insider (Form 3/4/5 filer). CIK 0001601264. Director at Nkarta, Inc. (NKTX) and 3 other issuers. 8 reported Form 4/5 transactions since Sep 2024; latest on Jun 10, 2026. Located in BERKELEY HEIGHTS, NJ.
Companies Dybbs Michael has filed insider reports for
- Nkarta, Inc. (NKTX): Director
- SUTRO BIOPHARMA, INC. (STRO): Director
- Kalaris Therapeutics, Inc. (KLRS): Director
- SpyGlass Pharma, Inc. (SGP): Director
Dybbs Michael
CIK: 0001601264
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Jun 10, 2026NKTX
Nkarta, Inc.
AwardDirectStock Option (right to buy)
37K shares- - Jun 5, 2026STRO
SUTRO BIOPHARMA, INC.
AwardDirectStock Option (right to buy)
10K shares- - Jun 3, 2026KLRS
Kalaris Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
9K shares- - Feb 5, 2026SGP
SpyGlass Pharma, Inc.
AwardDirectStock Option (right to buy)
27.4K shares- - Dec 23, 2025STRO
SUTRO BIOPHARMA, INC.
AwardDirectStock Option (right to buy)
1.5K shares- - Jun 6, 2025STRO
SUTRO BIOPHARMA, INC.
AwardDirectStock Option (right to buy)
50K shares- - Jun 5, 2025NKTX
Nkarta, Inc.
AwardDirectStock Option (right to buy)
46K shares- - Apr 10, 2025KLRS
Kalaris Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
18K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 10, 2026 |  NKTX Nkarta, Inc. | Award Stock Option (right to buy) | 37,000 | - | - | Direct |
| Jun 5, 2026 |  STRO SUTRO BIOPHARMA, INC. | Award Stock Option (right to buy) | 10,000 | - | - | Direct |
| Jun 3, 2026 |  KLRS Kalaris Therapeutics, Inc. | Award Stock Option (Right to Buy) | 9,000 | - | - | Direct |
| Feb 5, 2026 |  SGP SpyGlass Pharma, Inc. | Award Stock Option (right to buy) | 27,400 | - | - | Direct |
| Dec 23, 2025 | STRO SUTRO BIOPHARMA, INC. | Award Stock Option (right to buy) | 1,500 | - | - | Direct |
| Jun 6, 2025 | STRO SUTRO BIOPHARMA, INC. | Award Stock Option (right to buy) | 50,000 | - | - | Direct |
| Jun 5, 2025 | NKTX Nkarta, Inc. | Award Stock Option (right to buy) | 46,000 | - | - | Direct |
| Apr 10, 2025 | KLRS Kalaris Therapeutics, Inc. | Award Stock Option (Right to Buy) | 18,000 | - | - | Direct |
1-8 of 8 transactions